CR MEDICAL (01515) announced its interim results, with shareholders' profit amounting to 265 million yuan, a year-on-year decrease of 21.98%.

CR MEDICAL (01515) released its interim results for the six months ending June 30, 2026. The group achieved revenue of 4.479 billion yuan (RMB, the same below), a year-on-year decrease of 1.02%; profit attributable to shareholders was 265 million yuan, a year-on-year decrease of 21.98%; basic earnings per share were 0.21 yuan; and an interim dividend of 5 cents per share is proposed. The announcement stated that during the reporting period, the hospital business segment generated a revenue of 4.317 billion yuan, a year-on-year increase of 1.4%. Among this, outpatient and emergency visit numbers increased by 5.2%, and inpatient numbers grew by 0.3%; the average revenue per outpatient and emergency visit decreased by 6.1%, while the average revenue per inpatient grew by 3.1%. As of June 30, 2026, the group managed and operated 90 medical institutions across 10 provinces and cities in China. During the reporting period, the group's own hospitals saw approximately 5.37 million outpatient and emergency visits and 270,000 inpatient admissions, reflecting year-on-year increases of 5.2% and 0.3%, respectively.